Patents by Inventor Ted Wei

Ted Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11518299
    Abstract: A holographic projection system and method are implemented by a projection device provided on the vehicle; a water mist generating device for generating water mist provided on the vehicle; and a controller in communication with the projection device and the water mist generating device. The controller is configured to detect a signal of user proximity to the vehicle, and activate the water mist generating device and the projection device respectively based on the detected signal, so that the projection device projects an image onto the water mist.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: December 6, 2022
    Assignee: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Heidi Hu, Amy Zheng, Ted Wei, Jim Zhou, Rocky Lu
  • Publication number: 20210268959
    Abstract: A holographic projection system and method are implemented by a projection device provided on the vehicle; a water mist generating device for generating water mist provided on the vehicle; and a controller in communication with the projection device and the water mist generating device. The controller is configured to detect a signal of user proximity to the vehicle, and activate the water mist generating device and the projection device respectively based on the detected signal, so that the projection device projects an image onto the water mist.
    Type: Application
    Filed: February 19, 2021
    Publication date: September 2, 2021
    Applicant: Ford Global Technologies, LLC
    Inventors: Heidi Hu, Amy Zheng, Ted Wei, Jim Zhou, Rocky Lu
  • Publication number: 20060089408
    Abstract: The present invention is a method of treating blepharospasm with a prostaglandin derivative, comprising the steps of (a) providing a predetermined amount of prostaglandin derivative; and (b) applying the prostaglandin derivative in a predetermined position. The prostaglandin derivative is preferably in the form of latanoprost wherein the chemical composition of latanoprost is a prostaglandin F.sub.2.alpha derivative which has the chemical name isopropyl-(Z)-7[(1R,2R,3R,5S)3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl I]cyclo-pentyl]-5-heptenoate. The dosage of the prostaglandin derivative is generally in the range of 1.5 ug to 4.
    Type: Application
    Filed: October 22, 2004
    Publication date: April 27, 2006
    Inventors: Ted Wei, Ted Wei